When announcing its Q2 2025 results, Adama has given its view on the crop protection (CP) market, which could have implications for players in other inputs markets.

The company says that it has seen demand return to pre-pandemic levels. This follows what the company describes as a period of ‘extended destocking’. However, raw materials remain over-supplied and that is keeping prices under pressure.

From the end-user side, the company notes that farmer profitability remains tight due to low crop prices and higher interest rates. The effect of high interest rates is sustaining just-in-time purchasing, says the company.

Adama reported Q2 2025 sales of USD 968 million, a 3% increase on the same quarter in 2024. The company said this was the first year-over-year quarterly growth since Q3 2022. The company’s gross profit for the quarter also increased by 14% to USD 281 million.

The overall net profit was reported as a loss of USD 34 million for 1H 2025. This was a narrowing of the loss reported in 1H 2024 (USD 154 million).

Owned by ChemChina since 2016, Adama introduced a 3-year Fight Forward strategic plan in early 2024 to increase profits and cash flow. This was a response to factors including currency weakness in key Latin American markets, reduced farmer incomes, just-in-time purchasing, and lower crop protection prices.

More from New AG International

ADAMA Ltd. will distribute Groundwork BioAg’s Rootella mycorrhizal inoculant in the Chinese market.